[EN] SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE RÉCEPTEURS NMDA DE SPIRO-LACTAME ET UTILISATIONS ASSOCIÉES
申请人:APTINYX INC
公开号:WO2017201283A1
公开(公告)日:2017-11-23
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
申请人:Aptinyx Inc.
公开号:EP3458458B1
公开(公告)日:2020-11-04
PROCESSES FOR PRODUCTION OF INTERMEDIATES FOR 2-ALKYL CEPHEM COMPOUNDS
申请人:SHIONOGI & CO., LTD.
公开号:US20150291619A1
公开(公告)日:2015-10-15
The invention relates to processes for the production of intermediates for preparing 2-alkyl cephem compounds useful as antimicrobial drugs. The invention provides a process which comprises oxidating a compound of the formula (I) or a salt thereof to give a compound of the formula (II) or a salt thereof wherein each symbol is as defined in the specification.
US9527866B2
申请人:——
公开号:US9527866B2
公开(公告)日:2016-12-27
[EN] PROCESSES FOR PRODUCTION OF INTERMEDIATES FOR 2-ALKYL CEPHEM COMPOUNDS<br/>[FR] PROCÉDÉS DE PRODUCTION D'INTERMÉDIAIRES DE COMPOSÉS DE TYPE 2-ALKYLCEPHEM
申请人:SHIONOGI & CO
公开号:WO2014069649A1
公开(公告)日:2014-05-08
The invention relates to processes for the production of intermediates for preparing 2-alkyl cephem compounds useful as antimicrobial drugs. The invention provides a process which comprises oxidating a compound of the formula (I) or a salt thereof to give a compound of the formula (II) or a salt thereof wherein each symbol is as defined in the specification.